1. Market Research
  2. > Pharmaceutical
  3. > Drug Development Market Trends
Clinical Trial Design for Commercial Success

Clinical Trial Design for Commercial Success

  • June 2015
  • 72 pages
  • ID: 3090981
  • Format: PDF
  • By Firstword Pharma

Summary

Table of Contents




Clinical Trial Design for Commercial Success offers expert insights on how to best position drugs for success through strategic innovative design of clinical trials.

Clinical trials make up, on average, nearly 60 percent of the total development costs for a new drug, and marketplace success is by no means guaranteed. In this challenging environment, complacency in trial design and execution carries a heavy cost.

From launch to patent expiry, Clinical Trial Design for Commercial Success offers key insights on building clinical trials that give new drugs every advantage in the marketplace.









Top Benefits



Learn how strategic design of clinical trials can drive the commercial success of new therapies
Understand how to ‘design-in’ value creation so your clinical trial delivers data that influences payers and prescribers
Learn how to keep your clinical trials on track for commercial success from day one



Answers to Critical Questions

How can companies meet the need to deliver returns over the short- and long-term through the design and implementation of clinical trials?
Where and when does the process of designing clinical trials for commercial success start? Who are the key stakeholders that need be involved?
To what extent should commercial factors like pricing, branding, positioning and risk-benefit be factored into clinical development?
How do alternative trial designs and the generation of real-world data contribute to commercial success?



Experts Interviewed

Manolo Beelke, Senior Medical Director, Worldwide Clinical Trials
Cecil Nick, Vice President, Biotechnology, Parexel Consulting
Bob Swann, hHad of US P&MA, Heron Commercialization (Parexel)
Rick Sax, Senior Vice President, Clinical Design & Reporting Services, Quintiles
Dr Michael Kirchengast, Senior Vice President, Scientific Affairs, PRA Health Sciences
Leo James, Associate Director, Medical Affairs - Clinical Trials, Astellas Pharma
Dr Domenico Merante, Senior Director Clinical Development, Daiichi Sankyo, UK




About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence



FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Choroidal Neovascularization Global Clinical Trials Review, H1, 2020

Choroidal Neovascularization Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020

Choroidal Neovascularization Global Clinical Trials Review, H1, 2020Summaryclinical trial report, “Choroidal Neovascularization Global Clinical Trials Review, H1, 2020" provides an overview of Choroidal ...

Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2019

Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • December 2019

Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2019SummaryMedical Devices sector report, “Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiac ...

Diabetic Neuropathic Pain Global Clinical Trials Review, H2, 2019

Diabetic Neuropathic Pain Global Clinical Trials Review, H2, 2019

  • $ 2500
  • December 2019

Diabetic Neuropathic Pain Global Clinical Trials Review, H2, 2019Summaryclinical trial report, “Diabetic Neuropathic Pain Global Clinical Trials Review, H2, 2019" provides an overview of Diabetic Neuropathic ...


ref:plp2015

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on